Who We Are: Pharmaceutical Product Development & CDMO Pharma Services Specialists
UPM Pharmaceuticals is a bit of a rarity in the pharma manufacturing industry. We are an independent, family-owned contract development and pharma manufacturing organization (CDMO) with longstanding experience as a Big Pharma supplier and the commercial pedigree of more than 80 products brought to market. As a trusted pharmaceutical outsourcing partner, we combine enterprise-level capabilities with the flexibility and transparency that only a family-owned CDMO can offer.
ABOUT UPM CDMOWhat We Do: End-to-End CDMO Pharma Solutions & Contract Pharmaceutical Manufacturing Services
As a full-service contract development and manufacturing organization (CDMO), UPM Pharmaceuticals delivers expert drug formulation development and cGMP-compliant production of semi-solid and solid dose drug products. We have a particularly robust track record in late-stage commercial pharma manufacturing support, including technology transfer and scale-up capabilities that move your product efficiently from development to market.
Annual Production Capabilities
3.5B
Tablets
680M
Capsules
1,300
Metric Tons of Semi-Solids
What We Handle: Our CDMO Pharma Services & Manufacturing Capabilities
At UPM Pharmaceuticals, we partner with pharmaceutical companies of all sizes to deliver comprehensive CDMO pharma solutions — from drug formulation development and solid dosage form development to analytical, microbial, and stability testing. Over the last few decades, we have honed our expertise to specialize in the intricate processes involved in potent compound handling, hormones, and DEA-licensed controlled substances. Our pharma manufacturing support services can accommodate commercial transfer projects in both oral solids and semi-solids, involving up to hundreds of millions of doses annually.
Where It Happens: Our US-Based CDMO Pharmaceutical Manufacturing Facility in Bristol, TN
UPM Pharmaceuticals has been owned and operated by the same family business legacy for more than 25 years, establishing us as one of the leading US-based CDMOs in the industry. Our nearly 500,000 square-foot cGMP manufacturing facility has seen over 80 products advanced from proof of concept to commercialization and continues to support a growing portfolio of commercial CDMO pharma solutions. From drug formulation development and pharma manufacturing support to packaging and warehousing, we provide end-to-end contract pharmaceutical manufacturing services under one roof.
PHARMA MANUFACTURING FACILITY OVERVIEWFacility At A Glance
475,000 ft2
Commercial Pharma Manufacturing Facility
250,000 ft2
Warehouse
15,800 ft2
DEA-Approved Vault Space
7-Acre
Pharmaceutical Development Campus
UPM Pharmaceuticals Welcomes Back Pat Hatem as Vice President of Manufacturing and Packaging
READ ARTICLE